Latest Asx News

Scorpion Minerals reports promising near-surface high-grade gold at its Pharos Project and announces a strategic partnership with Gylden Resources to leverage processing capabilities in Western Australia.

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

FBR Limited unveiled its new DST-enabled Mantis welding robot targeting heavy fabrication sectors while completing key milestones on its Hadrian bricklaying technology and securing a $22 million financing package.

4DS Memory Limited reveals a pivotal quarter marked by a strategic review, executive departures, and a contentious board nomination ahead of its AGM.

Greenvale Energy’s maiden drilling at the Oasis Uranium Project delivers multiple high-grade uranium intercepts, while the company expands its tenure in the Northern Territory’s prolific Pine Creek region.

ClearVue Technologies has secured a $4.6 million capital raise and signed major partnerships, setting the stage for commercialisation in 2026 with a robust $60 million project pipeline.

Genmin Limited has made significant progress on its Baniaka iron ore project in Gabon, with PowerChina submitting competitive engineering and construction proposals and the company securing A$15 million in director-related loans during the quarter.

Metal Bank Limited is advancing its Western Australia gold strategy with significant resource development at Livingstone and a binding agreement to acquire Hastings Technology Metals’ WA gold assets, while also progressing critical minerals projects in Queensland and Saudi Arabia.

Alvo Minerals advances exploration at its Palma Copper-Zinc Project in Brazil, defining promising new prospects Touro and Esperanza with strong geochemical and geophysical signatures. The company also reviews rare earth projects amid rising market interest.

Horseshoe Metals has secured mining approval for Direct Shipping Ore operations at its Horseshoe Lights project, complemented by promising drilling assays and strategic funding to accelerate development.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

NT Minerals Limited reported a net cash outflow of A$590,000 for Q3 2025 but bolstered its liquidity with A$1.07 million from investing activities, leaving it with over two quarters of funding runway.